4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001628280-24-006725
Options or other derivatives
- Chief Financial Officer acquired 213,886 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Gerber Brianna · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-22 | Grant or award : show line 1 in the form Employee Stock Options (right to buy) | +213,886 | 213,886 | D |
Loading xslF345X05/wk-form4_1708740022.xml…